Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors

This study has been terminated.
(Administratively complete.)
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: January 4, 2002
Last updated: January 16, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)